Article Versions Notes

Lawal B, Kuo Y-C, Tang S-L, Liu F-C, Wu ATH, Lin H-Y, Huang H-S. Transcriptomic-Based Identification of the Immuno-Oncogenic Signature of Cholangiocarcinoma for HLC-018 Multi-Target Therapy Exploration. Cells. 2021; 10(11):2873. https://doi.org/10.3390/cells10112873

Lawal, Bashir, Yu-Cheng Kuo, Sung-Ling Tang, Feng-Cheng Liu, Alexander T. H. Wu, Hung-Yun Lin, and Hsu-Shan Huang. 2021. "Transcriptomic-Based Identification of the Immuno-Oncogenic Signature of Cholangiocarcinoma for HLC-018 Multi-Target Therapy Exploration" Cells 10, no. 11: 2873. https://doi.org/10.3390/cells10112873

Lawal, B., Kuo, Y.-C., Tang, S.-L., Liu, F.-C., Wu, A. T. H., Lin, H.-Y., & Huang, H.-S. (2021). Transcriptomic-Based Identification of the Immuno-Oncogenic Signature of Cholangiocarcinoma for HLC-018 Multi-Target Therapy Exploration. Cells, 10(11), 2873. https://doi.org/10.3390/cells10112873